IT8468281A0 - Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche - Google Patents

Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche

Info

Publication number
IT8468281A0
IT8468281A0 IT8468281A IT6828184A IT8468281A0 IT 8468281 A0 IT8468281 A0 IT 8468281A0 IT 8468281 A IT8468281 A IT 8468281A IT 6828184 A IT6828184 A IT 6828184A IT 8468281 A0 IT8468281 A0 IT 8468281A0
Authority
IT
Italy
Prior art keywords
proglumide
therapy
contain
pharmaceutical compositions
neoplastic diseases
Prior art date
Application number
IT8468281A
Other languages
English (en)
Other versions
IT8468281A1 (it
IT1179894B (it
Inventor
Angelo Luigi Rovati
Claudio Lucio Rovati
Francesco Makovec
Original Assignee
Rotta Research Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Lab filed Critical Rotta Research Lab
Priority to IT68281/84A priority Critical patent/IT1179894B/it
Publication of IT8468281A0 publication Critical patent/IT8468281A0/it
Priority to PCT/EP1985/000673 priority patent/WO1986003968A1/en
Priority to US06/900,152 priority patent/US4978683A/en
Priority to JP61500356A priority patent/JPH0667832B2/ja
Priority to EP86900107A priority patent/EP0235151B1/en
Priority to DE8686900107T priority patent/DE3582594D1/de
Publication of IT8468281A1 publication Critical patent/IT8468281A1/it
Application granted granted Critical
Publication of IT1179894B publication Critical patent/IT1179894B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT68281/84A 1984-12-27 1984-12-27 Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche IT1179894B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT68281/84A IT1179894B (it) 1984-12-27 1984-12-27 Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche
PCT/EP1985/000673 WO1986003968A1 (en) 1984-12-27 1985-12-05 Proglumide and pharmaceutical compositions containing it for use in the treatment of neoplastic affections
US06/900,152 US4978683A (en) 1984-12-27 1985-12-05 Proglumide and pharmaceutical compositions containing it for use in the treatment of neoplastic affections
JP61500356A JPH0667832B2 (ja) 1984-12-27 1985-12-05 腫瘍性疾患の治療に用いるプログルミド含有医薬組成物
EP86900107A EP0235151B1 (en) 1984-12-27 1985-12-05 Proglumide and pharmaceutical compositions containing it for use in the treatment of neoplastic affections
DE8686900107T DE3582594D1 (de) 1984-12-27 1985-12-05 Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT68281/84A IT1179894B (it) 1984-12-27 1984-12-27 Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche

Publications (3)

Publication Number Publication Date
IT8468281A0 true IT8468281A0 (it) 1984-12-27
IT8468281A1 IT8468281A1 (it) 1986-06-27
IT1179894B IT1179894B (it) 1987-09-16

Family

ID=11308819

Family Applications (1)

Application Number Title Priority Date Filing Date
IT68281/84A IT1179894B (it) 1984-12-27 1984-12-27 Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche

Country Status (6)

Country Link
US (1) US4978683A (it)
EP (1) EP0235151B1 (it)
JP (1) JPH0667832B2 (it)
DE (1) DE3582594D1 (it)
IT (1) IT1179894B (it)
WO (1) WO1986003968A1 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880938A (en) * 1986-06-16 1989-11-14 Merck & Co., Inc. Amino acid analogs
US5089638A (en) * 1986-06-16 1992-02-18 Merck & Co., Inc. Amino acid analogs as CCK-antagonists
SE8901149D0 (sv) * 1989-04-03 1989-04-03 Pharmacia Ab Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
EP0889735B1 (en) * 1996-02-08 2011-04-13 Cancer Advances, Inc., Immunological methods for the treatment of gastrointestinal cancer
CA2328501A1 (en) * 1998-05-15 1999-11-25 Aphton Corporation Prevention and treatment of hypergastrinemia
EP1372717A2 (en) 2001-03-23 2004-01-02 Aphton Corporation Combination treatment of pancreatic cancer
US20090191232A1 (en) 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
CN1525868A (zh) * 2001-07-09 2004-09-01 埃弗顿有限公司 治疗和预防肝脏、肺脏和食道的癌症和癌症前期症状
CN1781023A (zh) * 2003-03-28 2006-05-31 埃弗顿有限公司 胃泌素激素免疫测定
WO2005011665A1 (en) * 2003-07-22 2005-02-10 Arakis Ltd. The use of proglumide for the treatment of emesis
JP2008513536A (ja) 2004-09-22 2008-05-01 レセプター バイオロジックス インコーポレイテッド プロガストリンに対するモノクローナル抗体
GB2516436A (en) * 2013-07-20 2015-01-28 Pornthip Lattmann Benzydamine, an anti-neoplastic agent, acting as cholecystokinin antagonist Gl and brain cancers
WO2018232230A1 (en) 2017-06-15 2018-12-20 Cancer Advances Inc. Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer

Also Published As

Publication number Publication date
US4978683A (en) 1990-12-18
EP0235151B1 (en) 1991-04-17
DE3582594D1 (de) 1991-05-23
IT8468281A1 (it) 1986-06-27
WO1986003968A1 (en) 1986-07-17
JPS62501705A (ja) 1987-07-09
JPH0667832B2 (ja) 1994-08-31
IT1179894B (it) 1987-09-16
EP0235151A1 (en) 1987-09-09

Similar Documents

Publication Publication Date Title
IT1217783B (it) Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative
ITMI950568A0 (it) Formulazioni farmaceutiche in forma di gel tissotropico
FI20115742L (fi) Mometasonifuroaatin käyttö lääkkeen valmistuksessa
IT8467445A1 (it) Composizione e preparato per la somministrazione di medicamenti per via cutanea.
FI962154L (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
IT8468281A0 (it) Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche
NL970023I1 (nl) Medicamenten voor behandeling van oogontsteking.
ITRM940328A0 (it) "uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario".-
IT1148618B (it) Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo
AU2690684A (en) Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin
IT8548055A0 (it) Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
IT1160131B (it) Proglumide composizioni e preparati farmaceutici che la comprendono per l'impiego nella terapia umana del dolore
IT1170238B (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
ZA908490B (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
IT1191611B (it) Formalazioni farmaceutiche per stimolare la liberazione di ormone somatotropo
IT1194359B (it) Applicazione terapeutica del mazindolo nella malattia di parkinson
IT8422685A0 (it) Composizione farmaceutica eprocedimento per il trattamento di eccetazione psicomotoria.
IT1171692B (it) Preparato farmaceutico impiegabile per il trattamento della lebbra e/o di altre micobatteriosi
IT8248421A0 (it) Impiego di l-carnitina e di acil-lcarnitine nel trattamento terapeutico delle neoplasie
IT1282951B1 (it) Formulazioni farmaceutiche gastroresistenti contenenti colostro e uso del colostro per il trattamento dell'insonnia
ITMI920333A0 (it) Uso di sostanze parasimpaticomimetiche dirette per la terapia del dolore
ES542573A0 (es) Perfeccionamientos en la construccion de conjuntos funera- rios para enterramientos

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19931130